Liver Cancer Death Rate In US Surged 43% In 16 Years
(CNN) — Death rates from liver cancer increased 43% for American adults from 2000 to 2016, according to a report released Tuesday by the US Centers for Disease Control and Prevention’s National Center for Health Statistics. The increase comes even as mortality for all cancers combined has declined. Liver cancer death rates increased for both men and women 25 and older, as well as white, black and Hispanic people. Only Asians and Pacific Islanders saw a decrease in mortality from liver cancer. The rise in mortality doesn’t mean that liver cancer is deadlier than before, according to Dr. Jiaquan Xu, the aut...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 17, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cancer Liver Cancer Source Type: news

Tackling Stigma
Sadly, stigma around health conditions remains a part of many patients ’ lives. Many will not disclose a diagnosis for fear of being judged by peers, employers, health professionals, colleagues and wider society. In fact, there is clear evidence that such negative societal attitudes impact health outcomes, resulting in diagnosis delays and impaired treatment.Some diseases are heavily stigmatized – including mental health, HIV/AIDS, hepatitis and some skin conditions – leading people to restrict their participation in society, impairing their chances of living happy, healthy lives.However, to one extent or...
Source: EyeForPharma - July 17, 2018 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news

Real-world Use of Elbasvir-Grazoprevir in Chronic HCV Real-world Use of Elbasvir-Grazoprevir in Chronic HCV
This retrospective analysis evaluated outcomes of hepatitis C patients treated with elbasvir-grazoprevir with or without ribavirin in clinical practice settings in the United States.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 17, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Within Opioid Abuse Epidemic, Infectious Disease Epidemic Emerges Within Opioid Abuse Epidemic, Infectious Disease Epidemic Emerges
There is a new epidemic of hepatitis C, HIV, and other infections within the opioid abuse epidemic, according to participants in a National Academies of Sciences, Engineering, and Medicine workshop.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 16, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Routine screening, treatment can curb opioid abuse
Opioid abuse, as well as increases in HIV, hepatitis C and other infections, can be reduced with routinely screening and treatment when seeking other services. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 16, 2018 Category: Consumer Health News Source Type: news

Why Aren't Prison Inmates With Hepatitis C Being Treated?
As a matter of general health policy, states should aggressively treat hepatitis C in prisons. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 16, 2018 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NASDAQ:GILD NYSE:ABBV Source Type: news

Within opioid abuse epidemic, infectious disease epidemic emerges
NEW YORK (Reuters Health) - There is a new epidemic of hepatitis C, HIV, and other infections within the opioid abuse epidemic, according to participants in a National Academies of Sciences, Engineering, and Medicine workshop. (Source: Reuters: Health)
Source: Reuters: Health - July 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Dr. Sandra Springer: On the other epidemic fueled by the opioid crisis
Hospitals nationwide are being overwhelmed with a rise in diseases caused by opioid addiction, including Hepatitis C, HIV, and invasive bacterial infections. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 13, 2018 Category: Universities & Medical Training Source Type: news

HCV-Positive Kidneys Cost-Effective for HCV-Positive Recipients HCV-Positive Kidneys Cost-Effective for HCV-Positive Recipients
Quality-adjusted life expectancy is greater and costs are lower when kidney transplant candidates infected with hepatitis C virus (HCV) receive HCV-positive kidneys than when they receive HCV-negative kidneys, according to a cost-effectiveness analysis.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 13, 2018 Category: Transplant Surgery Tags: Transplantation News Source Type: news

Routine, coordinated treatment of opioid abuse can stem national epidemic
(Oregon Health& Science University) To help stem the nationwide opioid epidemic and related increases in HIV, hepatitis C and other infections, health care providers should routinely screen and treat patients for opioid abuse when they come to clinics and hospitals seeking other services. That's one of five recommendationsin a paper published in the Annals of Internal Medicine that supplements a document that outlines the proceedings of a March 12, 2018, workshop convened on the topic by the National Academies of Sciences, Engineering and Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2018 Category: International Medicine & Public Health Source Type: news

Expert panel compares opioid epidemic to early days of HIV epidemic
(American College of Physicians) Experts are drawing on lessons learned from the early days of the HIV epidemic to address the current opioid epidemic. As a result of widespread opioid abuse, new epidemics of hepatitis C virus (HCV) and HIV infection have arisen and hospitalizations for related infections have increased. An expert panel convened by the National Academies of Sciences, Engineering, and Medicine (NASEM) recommends five crucial steps for clinicians treating patients affected by opioid addiction and these intersecting infections. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 13, 2018 Category: International Medicine & Public Health Source Type: news

Early hepatitis C infection: How often does it become chronic?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - July 13, 2018 Category: Consumer Health News Source Type: news

Interview with HCV Expert Paul Kwo, MD
Patient Care talked with Dr Kwo about recent updates to hepatitis C management guidelines, challenges in expanding screening, and more. (Source: ConsultantLive)
Source: ConsultantLive - July 12, 2018 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Hepatitis C Source Type: news

How to Improve HCV Screening Rates: A 6-Step QI Experience
HCV screening rates improved at one large clinic from 24% to over 90% and were sustained at 1 year. How? With this 6-step intervention. (Source: ConsultantLive)
Source: ConsultantLive - July 11, 2018 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Hepatitis C Source Type: news

Universal Screening Best Strategy for Hepatitis C in France
WEDNESDAY, July 11, 2018 -- Universal screening is the most effective strategy for hepatitis C virus (HCV) in France, according to a study published online July 1 in the Journal of Hepatology. Sylvie Deuffic-Burban, from the Universit é Paris... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 11, 2018 Category: Pharmaceuticals Source Type: news

Hepatitis C vaccine could dramatically reduce transmission in people who inject drugs
(Loyola University Health System) Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users. A study published in Science Translational Medicine shows that if a hepatitis C vaccine were successfully developed, it would dramatically reduce transmission of hepatitis C among drug users -- even though it's unlikely such a vaccine would provide complete immunity. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 11, 2018 Category: International Medicine & Public Health Source Type: news

HCV-Infected Kidney Transplant More Efficient in HCV-Infected
TUESDAY, July 10, 2018 -- For patients with hepatitis C virus (HCV) infection with end-stage renal disease, transplant of an HCV-infected kidney followed by treatment is more cost-effective than transplant of an HCV-uninfected kidney, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2018 Category: Pharmaceuticals Source Type: news

Hepatitis-Infected Kidneys May Be Safe New Option for Transplant
MONDAY, July 9, 2018 -- If they're already infected with hepatitis C virus (HCV), patients in need of a kidney transplant might safely receive an organ from an HCV-infected donor, a new study maintains. Using hepatitis C-infected kidneys for this... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 9, 2018 Category: General Medicine Source Type: news

Using hepatitis C-infected donor kidneys could reduce time on dialysis for transplant patients with HCV
(University of Cincinnati Academic Health Center) Transplanting hepatitis C-infected dialysis patients with HCV-positive donor organs and then treating the infection later is more effective, cheaper and shortens organ wait time. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 9, 2018 Category: Infectious Diseases Source Type: news

Assessing Hepatitis C Spontaneous Clearance Assessing Hepatitis C Spontaneous Clearance
How common is clearance of HCV without treatment, and how does this vary over time? What demographic and clinical factors are associated with spontaneous clearance?Journal of Viral Hepatitis (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - July 6, 2018 Category: Pathology Tags: Gastroenterology Journal Article Source Type: news

Natco Pharma launches Hepatitis C drug in India
Natco Pharma launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcinat Plus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 2, 2018 Category: Pharmaceuticals Source Type: news

Cost-effective universal screening for hepatitis C in France
(ANRS) An estimated 75,000 people in France are unaware they are infected by hepatitis C virus. An ANRS-funded study by Sylvie Deuffic-Burban, a research associate at IAME (Inserm - Universit é Paris Diderot - Universit é Paris 13), and her team shows that a universal screening strategy applied to hepatitis C is cost-effective and improves life expectancy in those infected, compared with targeted screening. These modeling results will be published on July 1, 2018, in Journal of Hepatology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 1, 2018 Category: International Medicine & Public Health Source Type: news

Fight Against Drug Consumption Needs Gender Specific Treatments
By Carmen Arroyo and Emily ThampoeUNITED NATIONS, Jun 29 2018 (IPS)The World Drug Report 2018, launched this week by the United Nations Office on Drugs and Crime (UNODC), highlighted the importance of gender in drug consumption and behaviour, suggesting it is essential to provide different types of health-care and legal solutions. Only one in five women addicts seeks treatment for drug abuse, the president of the International Narcotics Board (INCB) has warned. Credit: UN Photo/D. GairAs Marie Nougier, Head of Research and Communications at the International Drug Policy Consortium (IDPC) told IPS: “There is certainly...
Source: IPS Inter Press Service - Health - June 29, 2018 Category: International Medicine & Public Health Authors: Carmen Arroyo and Emily Thampoe Tags: Active Citizens Development & Aid Economy & Trade Global Headlines Health TerraViva United Nations Trade & Investment Source Type: news

Hepatitis C treatment in the new DAA era: frontline implications
June 29, 2018 1:00-2:30pm ET.(CATIE) (Source: PHPartners.org)
Source: PHPartners.org - June 28, 2018 Category: International Medicine & Public Health Source Type: news

Medication Assisted Treatment (MAT) as HIV and Hepatitis C Prevention
June 29, 2018 1:00-3:00pm ET.(Help Free NYC) (Source: PHPartners.org)
Source: PHPartners.org - June 28, 2018 Category: International Medicine & Public Health Source Type: news

Direct-Acting Antivirals Effective for Hepatitis C in Seniors
MONDAY, June 25, 2018 -- For older patients with hepatitis C virus (HCV), direct-acting antiviral (DAA) therapy is effective, according to a study published online May 25 in the Journal of the American Geriatrics Society. Chiara Mazzarelli, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 25, 2018 Category: Pharmaceuticals Source Type: news

Laws That Criminalize Spread Of Infectious Diseases Can Increase Their Stigma
About a dozen states have added hepatitis C to the list of medical conditions for which people can face criminal prosecution if they knowingly engage in activities that could spread the disease.(Image credit: James Cavallini/Science Source) (Source: NPR Health and Science)
Source: NPR Health and Science - June 22, 2018 Category: Consumer Health News Authors: Michelle Andrews Source Type: news

Digital health news briefs: STD testing at home, VR distraction therapy
Finding time to get tested. Patients may now be able to address sexual healthcare issues through video conferencing. KnowNow Health has just launched a new website called App:KnowNOWSTD.com. The platform offers online lab testing for STDs including HIV, Gonorrhea, Chlamydia, Syphilis, Hepatitis C and Hepatitis B. The platform will also be able to offer care for women health conditions including urinary tract infections, bacterial vaginosis and yeast infections. (Source: mobihealthnews)
Source: mobihealthnews - June 21, 2018 Category: Information Technology Source Type: news

Hep C Guidance Update Quiz: Special Populations
The newest HCV guidance is out on special populations. Are you up to date? Take our short, 5-question quiz to find out.   (Source: ConsultantLive)
Source: ConsultantLive - June 21, 2018 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Hepatitis C Source Type: news

State court lets Kwiatkowski case move ahead
A Pennsylvania state court has allowed a lawsuit to move ahead against the...Read more on AuntMinnie.comRelated Reading: ARRT responds to Newsweek article on Kwiatkowski Former RT Kwiatkowski reveals drug diversion secrets Kwiatkowski sentenced to 39 years in prison Kwiatkowski pleads guilty in hepatitis C case NH report slams Exeter Hospital procedures in hepatitis C outbreak (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 21, 2018 Category: Radiology Source Type: news

Legal fight winding down in hospital hepatitis C case
A hospital has settled with a staffing agency but is still suing a registry organization over a traveling medical technician who infected dozens of patients in multiple states with hepatitis C before his arrest in 2012 (Source: ABC News: Health)
Source: ABC News: Health - June 20, 2018 Category: Consumer Health News Tags: Health Source Type: news

Compound made inside human body stops viruses from replicating
(Penn State) A team of researchers has identified the mode of action of viperin, a naturally occurring enzyme in humans and other mammals that is known to have antiviral effects on viruses such as West Nile, hepatitis C, rabies, and HIV. This discovery could allow researchers to develop a drug that could act as a broad-spectrum therapy for a range of viruses, including Zika. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 20, 2018 Category: Infectious Diseases Source Type: news

Neuroimaging in Hepatitis C Chronic Infection Neuroimaging in Hepatitis C Chronic Infection
By way of neuroimaging studies, this review aimed to characterize the structural and functional impact of hepatitis C infection on the brain and central nervous system.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

What to do for relapsers after hepatitis C treatment?
Title: What to do for relapsers after hepatitis C treatment?Category: Doctor's& Expert's views on SymptomsCreated: 8/25/2000 7:54:00 AMLast Editorial Review: 6/13/2018 2:55:08 PM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 13, 2018 Category: Nutrition Source Type: news

Minister: 'We got it wrong on Hep C drug'
A health minister said the NHS needs to be better prepared for the budget impact of new medicines such as the oral drug for Hepatitis C, and admitted “we didn’t get it right”. (Source: HSJ)
Source: HSJ - June 12, 2018 Category: UK Health Source Type: news

National HCV Elimination Programs Show Early Success in Treatment and Cure
Two new international studies on HCV show elimination programs have high levels of engagement, treatment initiation, and cure rates.   (Source: ConsultantLive)
Source: ConsultantLive - June 12, 2018 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Hepatitis C Source Type: news

Where Direct Acting Agents Fail, a New Retreatment Strategy May Win
For patients infected with hepatitis C virus who do not respond to direct-acting antiviral agents, results of a new study could mean a much brighter future. (Source: ConsultantLive)
Source: ConsultantLive - June 11, 2018 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Hepatitis C Source Type: news

Superbug Infections Rising Among Injection Drug Users
NEW YORK (AP) — One type of superbug bacteria is increasingly spreading among people who inject drugs, according to a new government report. Users of heroin and other injection drugs were 16 times more likely than other people to develop severe illnesses from MRSA, said the report published Thursday. "Drug use has crept up and now accounts for a substantial proportion of these very serious infections," said Dr. William Schaffner of Vanderbilt University, one of the study's authors. The U.S. is in the midst of its deadliest drug epidemic ever. While overdose deaths have been the main concern, some studies ha...
Source: JEMS Patient Care - June 8, 2018 Category: Emergency Medicine Authors: Mike Stobbe, Associated Press Tags: Patient Care News Source Type: news

Superbug Infections Rising Among Injection Drug Users
NEW YORK (AP) — One type of superbug bacteria is increasingly spreading among people who inject drugs, according to a new government report. Users of heroin and other injection drugs were 16 times more likely than other people to develop severe illnesses from MRSA, said the report published Thursday. "Drug use has crept up and now accounts for a substantial proportion of these very serious infections," said Dr. William Schaffner of Vanderbilt University, one of the study's authors. The U.S. is in the midst of its deadliest drug epidemic ever. While overdose deaths have been the main concern, some studies ha...
Source: JEMS: Journal of Emergency Medical Services News - June 8, 2018 Category: Emergency Medicine Authors: Mike Stobbe, Associated Press Tags: Patient Care News Source Type: news

One-third of Patients Denied New Hepatitis C Drugs One-third of Patients Denied New Hepatitis C Drugs
Despite an overall greater availability of direct-acting antivirals, absolute denials by insurers increased during 2016-2017 and remained high regardless of insurance type.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 7, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

One-third of hepatitis C prescriptions rejected by insurers, study says
Public and private health insurers have denied more than one-third of claims for hepatitis C drugs because they can cost several thousand dollars a month. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 7, 2018 Category: Consumer Health News Source Type: news

Insurance denials for new hepatitis C drugs remain high nationwide, study suggests
(Infectious Diseases Society of America) Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the US in 2014. But both public and private insurers continue to deny coverage for these costly drugs at high rates nationwide, despite efforts to remove treatment restrictions, according to a new study published in Open Forum Infectious Diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2018 Category: International Medicine & Public Health Source Type: news

Half of hepatitis C patients with private insurance denied life-saving drugs
(University of Pennsylvania School of Medicine) The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States. Private insurers had the highest denial rates, with 52.4 percent of patients denied coverage, while Medicaid denied 34.5 percent of patients and Medicare denied 14.7 percent. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2018 Category: International Medicine & Public Health Source Type: news

Post-Transplant Tx Reduces Wait for Kidney in Hep C & #43; Patients
WEDNESDAY, June 6, 2018 -- Post-transplant hepatitis C treatment increases access to transplant and reduces waitlist time among hepatitis C-positive patients awaiting kidney transplantation, according to a study published online May 14 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 6, 2018 Category: Pharmaceuticals Source Type: news

New guidelines recommend hepatitis C screening be done for those born between 1945 and 1975
Canadians born between 1945 and 1975 — essentially the baby-boom generation — should be tested for the potentially liver-destroying virus hepatitis C, a new set of guidelines recommends. (Source: CBC | Health)
Source: CBC | Health - June 3, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

New guidelines recommend hepatitis C screening for those born between 1945 and 1975
Canadians born between 1945 and 1975 should be tested for the potentially liver-destroying virus hepatitis C, a new set of guidelines recommends. (Source: CBC | Health)
Source: CBC | Health - June 3, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Screening for Hepatitis C Climbs in Colorado
The rate of screening for hepatitis C among Coloradans nearly tripled between 2011 and 2016, a Colorado Health Institute analysis of newly available data shows. (Source: PHPartners.org)
Source: PHPartners.org - May 31, 2018 Category: International Medicine & Public Health Source Type: news